Fierce Drug Dev Forum 2019 has ended
Back To Schedule
Monday, October 28 • 11:15am - 12:00pm
Uncertainty, Challenges, and Implications of Today’s Reimbursement Environment on the Deal-Making Landscape and Beyond

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Consider the rising importance of a product’s commercial versus clinical success when evaluating a potential target 
  • Discuss the impact of payer consolidation and the evolving healthcare landscape 
  • Explore how pricing practices have drawn public and government scrutiny and how this close examination has impacted deal structuring 

avatar for Nayahmka McGriff-Lee

Nayahmka McGriff-Lee

Product and Portfolio Strategy Director, Early Pipeline and Portfolio Strategy, GSK
avatar for Peter Trybus

Peter Trybus

Senior Corporate Counsel, Healthcare Law, GENENTECH
avatar for Tim Mayleben

Tim Mayleben

avatar for Kia Motesharei, Ph.D.

Kia Motesharei, Ph.D.

Former Vice President, Global Head of Business Development, Neurology and Immunology, EMD SERONO
Kia Motesharei most recently has been Vice President, Global Head Licensing & Business Development, Neurology & Immunology at EMD Serono (Merck outside the US and Canada).  He was a member of Franchise Leadership Team and is responsible for all partnering and licensing transactions... Read More →

Monday October 28, 2019 11:15am - 12:00pm PDT